LyondellBasell Targets $73 with 25.4% Upside as Antipodes Hikes Stake 13.9%
KeyBanc raised LyondellBasell’s price target to $73, implying a 25.41% upside from current levels. Antipodes Partners increased its stake by 13.9% to 238,718 shares valued at about $11.7 million, while other institutions also boosted their positions.
1. Price Target and Upside
KeyBanc set a $73 price target for LyondellBasell, signaling analysts expect a 25.41% increase from current trading levels. This adjustment reflects renewed confidence in the company’s specialty chemicals business and potential margin expansion.
2. Antipodes Partners Stake Increase
Antipodes Partners boosted its holding in LyondellBasell by 13.9%, now owning 238,718 shares worth approximately $11.7 million. The move underscores the firm’s positive outlook on the company’s cash flow generation and long-term growth prospects.
3. Other Institutional Movements
New York Life Investment Management raised its LYB stake by 0.5% to 38,521 shares, while the State of Michigan Retirement System added 0.3%, indicating broader institutional interest. These smaller increases suggest a consensus view on the stock’s near-term potential.
4. Trading Range and Market Position
LYB’s shares have traded between $55.39 and $58.56 today, reflecting moderate volatility. With a market capitalization near $18.75 billion and over 6.8 million shares changing hands, investor activity remains robust around these developments.